Sionna Therapeutics, Inc. (SION) — Financial statements
Income statement, balance sheet, and cash flow for Sionna Therapeutics, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.65↓3.1% | 0.67 | 0.00 | 0.00 | |
| Gross Profit | -0.65↑3.1% | -0.67 | 0.00 | 0.00 | |
| Operating Expenses | |||||
| R&D Expenses | 60↑5.2% | 57↑41.0% | 41↑17.4% | 35 | |
| General & Administrative Expenses | 29↑116.5% | 13↑36.7% | 10↑43.4% | 7 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 29↑116.5% | 13↑36.7% | 10↑43.4% | 7 | |
| Other Expenses | -0.65↑3.1% | -0.67 | 0.00 | 0.00 | |
| Operating Expenses | 88↑26.4% | 70↑38.9% | 50↑21.7% | 41 | |
| Total Costs & Expenses | 89↑26.1% | 71↑40.2% | 50↑21.7% | 41 | |
| Operating Results | |||||
| Operating Income | -89↓26.1% | -71↓40.2% | -50↓21.7% | -41 | |
| Depreciation & Amortization | 0.65↓3.1% | 0.67↑14.6% | 0.58↑377.9% | 0.12 | |
| EBITDA | -88↓26.4% | -70↓40.5% | -50↓20.6% | -41 | |
| EBIT | -89↓26.1% | -71↓40.2% | -50↓21.7% | -41 | |
| Interest & Other Income | |||||
| Net Interest Income | 13↑62.7% | 8↑195.1% | 3↑144.6% | 1 | |
| Interest Income | 13↑62.7% | 8↑195.1% | 3↑144.6% | 1 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 14↑54.6% | 9↑188.9% | 3↑171.2% | 1 | |
| Income Before Tax | -75↓22.0% | -62↓30.5% | -47↓17.5% | -40 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -75↓22.0% | -62↓30.5% | -47↓17.5% | -40 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -75↓22.0% | -62↓30.5% | -47↓17.5% | -40 | |
| Bottom-Line Net Income | -75↓22.0% | -62↓30.5% | -47↓17.5% | -40 | |
| EPS (Basic) | -1.88↓34.3% | -1.40↓30.7% | -1.07↓17.4% | -0.91 | |
| EPS (Diluted) | -1.88↓34.3% | -1.40↓30.7% | -1.07↓17.4% | -0.91 | |
| Weighted Average Shares | 40↓9.4% | 44↑0.0% | 44↑0.0% | 44 | |
| Weighted Average Diluted Shares | 40↓9.4% | 44↑0.0% | 44↑0.0% | 44 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.